Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet for persistent hyperparathyroidism after kidney transplantation
2007-002534-11Phase 3Active
- Sponsor
- CHU Caen Normandie
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cinacalcet in hyperparathyroidism, sponsored by CHU Caen Normandie. Primary endpoint: Bone mineral density change. Started Jun 2007; status: active.
02
Drugs
cinacalcet
03
Conditions
hyperparathyroidism
Beyond the preview
Go deeper on 2007-002534-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002534-11.